|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sun KX, Zheng RS, Zeng HM, Zhang SW, Zou
XN, Gu XY, Xia CF, Yang ZX, Li H, Chen WQ and He J: The incidence
and mortality of lung cancer in China, 2014. Zhonghua Zhong Liu Za
Zhi. 40:805–811. 2018.(In Chinese). PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen W, Zheng R, Zeng H and Zhang S:
Epidemiology of lung cancer in China. Thorac Cancer. 6:209–215.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nakanishi Y, Chen S, Inutsuka S, Ma Y,
Jiang X, Hara N, Sera N and Tokiwa H: Possible role of indoor
environment and coal combustion emission in lung carcinogenesis in
Fuyuan County, China. Neoplasma. 44:69–72. 1997.PubMed/NCBI
|
|
6
|
Chen G, Sun X, Ren H, Wan X, Huang H, Ma
X, Ning B, Zou X, Hu W and Yang G: The mortality patterns of lung
cancer between 1990 and 2013 in Xuanwei, China. Lung Cancer.
90:155–160. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu H, Meng S, Xu Q, Wang X, Wang J, Gong
R, Song Y, Duan Y and Zhang Y: Gene expression profiling of lung
adenocarcinoma in Xuanwei, China. Eur J Cancer Prev. 25:508–517.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mumford JL, He XZ, Chapman RS, Cao SR,
Harris DB, Li XM, Xian YL, Jiang WZ, Xu CW, Chuang JC, et al: Lung
cancer and indoor air pollution in Xuan Wei, China. Science.
235:217–220. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiang CL, He SW, Zhang YD, Duan HX, Huang
T, Huang YC, Li GF, Wang P, Ma LJ, Zhou GB and Cao Y: Air pollution
and DNA methylation alterations in lung cancer: A systematic and
comparative study. Oncotarget. 8:1369–1391. 2017.PubMed/NCBI
|
|
10
|
He XZ, Chen W, Liu ZY and Chapman RS: An
epidemiological study of lung cancer in Xuan Wei County, China:
Current progress. Case-control study on lung cancer and cooking
fuel. Environ Health Perspect. 94:9–13. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lan Q, Chapman RS, Schreinemachers DM,
Tian LW and He XZ: Household stove improvement and risk of lung
cancer in Xuanwei, China. J Natl Cancer Inst. 94:826–835. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang J, Li G, Huang Y, Ye L, Zhou Y, Zhao
G, Lei Y, Chen X, Wang K, Chen Y, et al: Association of inorganics
accumulation with the activation of NF-κB signaling pathway and the
iNOS expression of lung tissue in xuanwei lung cancer patients.
Zhongguo Fei Ai Za Zhi. 19:30–37. 2016.(In Chinese). PubMed/NCBI
|
|
13
|
Wakelee H, Kelly K and Edelman MJ: 50
Years of progress in the systemic therapy of non-small cell lung
cancer. Am Soc Clin Oncol Educ Book. 177–189. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ettinger DS, Aisner DL, Wood DE, Akerley
W, Bauman J, Chang JY, Chirieac LR, D'Amico TA, Dilling TJ,
Dobelbower M, et al: NCCN guidelines insights: non-small cell lung
cancer, version 5.2018. J Natl Compr Canc Netw. 16:807–821. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen Z, Fillmore CM, Hammerman PS, Kim CF
and Wong KK: Non-small-cell lung cancers: A heterogeneous set of
diseases. Nat Rev Cancer. 14:535–546. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aguilar EJ, Ricciuti B, Gainor JF, Kehl
KL, Kravets S, Dahlberg S, Nishino M, Sholl LM, Adeni A, Subegdjo
S, et al: Outcomes to first-line pembrolizumab in patients with
non-small-cell lung cancer and very high PD-L1 expression. Ann
Oncol. 30:1653–1659. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Grelet S and Howe PH: hnRNP E1 at the
crossroads of translational regulation of epithelial-mesenchymal
transition. J Cancer Metastasis Treat. 5(pii): 162019.PubMed/NCBI
|
|
18
|
Sherman EJ, Mitchell DC and Garner AL: The
RNA-binding protein SART3 promotes miR-34a biogenesis and G1 cell
cycle arrest in lung cancer cells. J Biol Chem. 294:17188–17196.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jung JH, Lee H, Cao B, Liao P, Zeng SX and
Lu H: RNA-binding motif protein 10 induces apoptosis and suppresses
proliferation by activating p53. Oncogene. Oct 7–2019.(Epub ahead
of print).
|
|
20
|
Pereira B, Billaud M and Almeida R:
RNA-binding proteins in cancer: Old players and new actors. Trends
Cancer. 3:506–528. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Y, Yang L, Ling C and Heng W: HuR
facilitates cancer stemness of lung cancer cells via regulating
miR-873/CDK3 and miR-125a-3p/CDK3 axis. Biotechnol Lett.
40:623–631. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao W, Lu D, Liu L, Cai J, Zhou Y, Yang
Y, Zhang Y and Zhang J: Insulin-like growth factor 2 mRNA binding
protein 3 (IGF2BP3) promotes lung tumorigenesis via attenuating p53
stability. Oncotarget. 8:93672–93687. 2017.PubMed/NCBI
|
|
23
|
Guan R, El-Rass S, Spillane D, Lam S, Wang
Y, Wu J, Chen Z, Wang A, Jia Z, Keating A, et al: rbm47, a novel
RNA binding protein, regulates zebrafish head development. Dev Dyn.
242:1395–1404. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yeganeh M, Seyedjafari E, Kamrani FA and
Ghaemi N: RNA-binding protein Rbm47 binds to Nanog in mouse
embryonic stem cells. Mol Biol Rep. 40:4391–4396. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fossat N, Tourle K, Radziewic T, Barratt
K, Liebhold D, Studdert JB, Power M, Jones V, Loebel DA and Tam PP:
C to U RNA editing mediated by APOBEC1 requires RNA-binding protein
RBM47. EMBO Rep. 15:903–910. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vanharanta S, Marney CB, Shu W, Valiente
M, Zou Y, Mele A, Darnell RB and Massagué J: Loss of the
multifunctional RNA-binding protein RBM47 as a source of selectable
metastatic traits in breast cancer. Elife. 3:2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sakurai T, Isogaya K, Sakai S, Morikawa M,
Morishita Y, Ehata S, Miyazono K and Koinuma D: RNA-binding motif
protein 47 inhibits Nrf2 activity to suppress tumor growth in lung
adenocarcinoma. Oncogene. 36:50832017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ettinger DS, Wood DE, Aggarwal C, Aisner
DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac
LR, et al: NCCN guidelines insights: Non-small cell lung cancer,
version 1.2020. J Natl Compr Canc Netw. 17:1464–1472. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fu QF, Liu Y, Fan Y, Hua SN, Qu HY, Dong
SW, Li RL, Zhao MY, Zhen Y, Yu XL, et al: Alpha-enolase promotes
cell glycolysis, growth, migration, and invasion in non-small cell
lung cancer through FAK-mediated PI3K/AKT pathway. J Hematol Oncol.
8:222015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Suwei D, Liang Z, Zhimin L, Ruilei L,
Yingying Z, Zhen L, Chunlei G, Zhangchao L, Yuanbo X, Jinyan Y, et
al: NLK functions to maintain proliferation and stemness of NSCLC
and is a target of metformin. J Hematol Oncol. 8:1202015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zeng B, Ge C, Li R, Zhang Z, Fu Q, Li Z,
Lin Z, Liu L, Xue Y, Xu Y, et al: Knockdown of microsomal
glutathione S-transferase 1 inhibits lung adenocarcinoma cell
proliferation and induces apoptosis. Biomed Pharmacother.
121:1095622019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lian S, Li L, Zhou Y, Liu Z and Wang L:
The co-expression networks of differentially expressed RBPs with
TFs and LncRNAs related to clinical TNM stages of cancers. PeerJ.
7:e76962019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu G, Zhang Q, Xia L, Shi M, Cai J, Zhang
H, Li J, Lin G, Xie W, Zhang Y and Xu N: RNA-binding protein CELF6
is cell cycle regulated and controls cancer cell proliferation by
stabilizing p21. Cell Death Dis. 10:6882019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hong YG, Xu GS, Yu GY, Zhou JD, Liu QZ, Ni
JS, Yan HL, Zhang W and Hao LQ: The RNA binding protein
neuro-oncological ventral antigen 1 (NOVA1) regulates IL-6 mRNA
stability to enhance JAK2-STAT3 signaling in CRC. Surg Oncol.
31:67–74. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Busà R, Paronetto MP, Farini D,
Pierantozzi E, Botti F, Angelini DF, Attisani F, Vespasiani G and
Sette C: The RNA-binding protein Sam68 contributes to proliferation
and survival of human prostate cancer cells. Oncogene.
26:4372–4382. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Vo DT, Subramaniam D, Remke M, Burton TL,
Uren PJ, Gelfond JA, de Sousa Abreu R, Burns SC, Qiao M, Suresh U,
et al: The RNA-binding protein Musashi1 affects medulloblastoma
growth via a network of cancer-related genes and is an indicator of
poor prognosis. Am J Pathol. 181:1762–1772. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wurth L, Papasaikas P, Olmeda D, Bley N,
Calvo GT, Guerrero S, Cerezo-Wallis D, Martinez-Useros J,
García-Fernández M, Hüttelmaier S, et al: UNR/CSDE1 drives a
post-transcriptional program to promote melanoma invasion and
metastasis. Cancer Cell. 30:694–707. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hopkins TG, Mura M, Al-Ashtal HA, Lahr RM,
Abd-Latip N, Sweeney K, Lu H, Weir J, El-Bahrawy M, Steel JH, et
al: The RNA-binding protein LARP1 is a post-transcriptional
regulator of survival and tumorigenesis in ovarian cancer. Nucleic
Acids Res. 44:1227–1246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yong H, Zhu H, Zhang S, Zhao W, Wang W,
Chen C, Ding G, Zhu L, Zhu Z, Liu H, et al: Prognostic value of
decreased expression of RBM4 in human gastric cancer. Sci Rep.
6:282222016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Glisovic T, Bachorik JL, Yong J and
Dreyfuss G: RNA-binding proteins and post-transcriptional gene
regulation. FEBS Lett. 582:1977–1986. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Biswas J, Patel VL, Bhaskar V, Chao JA,
Singer RH and Eliscovich C: The structural basis for RNA
selectivity by the IMP family of RNA-binding proteins. Nat Commun.
10:44402019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bechara EG, Sebestyén E, Bernardis I,
Eyras E and Valcárcel J: RBM5, 6, and 10 differentially regulate
NUMB alternative splicing to control cancer cell proliferation. Mol
Cell. 52:720–733. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hernández J, Bechara E, Schlesinger D,
Delgado J, Serrano L and Valcárcel J: Tumor suppressor properties
of the splicing regulatory factor RBM10. RNA Biol. 13:466–472.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang Z, Huang A, Zhang A and Zhou C: HuR
promotes breast cancer cell proliferation and survival via binding
to CDK3 mRNA. Biomed Pharmacother. 91:788–795. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Mitsunari K, Miyata Y, Asai A, Matsuo T,
Shida Y, Hakariya T and Sakai H: Human antigen R is positively
associated with malignant aggressiveness via upregulation of cell
proliferation, migration, and vascular endothelial growth factors
and cyclooxygenase-2 in prostate cancer. Transl Res. 175:116–128.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang W, Caldwell MC, Lin S, Furneaux H and
Gorospe M: HuR regulates cyclin A and cyclin B1 mRNA stability
during cell proliferation. EMBO J. 19:2340–2350. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wu M, Tong CWS, Yan W, To KKW and Cho WCS:
The RNA binding protein HuR: A promising drug target for anticancer
therapy. Curr Cancer Drug Targets. 19:382–399. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Prabhu VV and Devaraj N: Regulating RNA
binding motif 5 gene expression-A novel therapeutic target for lung
cancer. J Environ Pathol Toxicol Oncol. 36:99–105. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kavianpour M, Ahmadzadeh A, Shahrabi S and
Saki N: Significance of oncogenes and tumor suppressor genes in AML
prognosis. Tumour Biol. 37:10041–10052. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Jiang QQ and Liu WB: miR-25 Promotes
Melanoma Progression by regulating RNA binding motif protein 47.
Med Sci (Paris). 34 Focus(Issue F1): 59–65. 2018. View Article : Google Scholar
|
|
52
|
Wang TW, Vermeulen RC, Hu W, Liu G, Xiao
X, Alekseyev Y, Xu J, Reiss B, Steiling K, Downward GS, et al:
Gene-expression profiling of buccal epithelium among non-smoking
women exposed to household air pollution from smoky coal.
Carcinogenesis. 36:1494–1501. 2015.PubMed/NCBI
|
|
53
|
Wei Y, Zhang F, Zhang Y, Wang X, Xing C,
Guo J, Zhang H, Suo Z, Li Y, Wang J, et al: Post-transcriptional
regulator Rbm47 elevates IL-10 production and promotes the
immunosuppression of B cells. Cell Mol Immunol. 16:580–589. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Xuan Y, Wang J, Ban L, Lu JJ, Yi C, Li Z,
Yu W, Li M, Xu T, Yang W, et al: hnRNPA2/B1 activates
cyclooxygenase-2 and promotes tumor growth in human lung cancers.
Mol Oncol. 10:610–624. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wei TY, Juan CC, Hisa JY, Su LJ, Lee YC,
Chou HY, Chen JM, Wu YC, Chiu SC, Hsu CP, et al: Protein arginine
methyltransferase 5 is a potential oncoprotein that upregulates G1
cyclins/cyclin-dependent kinases and the phosphoinositide
3-kinase/AKT signaling cascade. Cancer Sci. 103:1640–1650. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Su LJ, Chang CW, Wu YC, Chen KC, Lin CJ,
Liang SC, Lin CH, Whang-Peng J, Hsu SL, Chen CH and Huang CY:
Selection of DDX5 as a novel internal control for Q-RT-PCR from
microarray data using a block bootstrap re-sampling scheme. BMC
Genomics. 8:1402007. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lu TP, Tsai MH, Lee JM, Hsu CP, Chen PC,
Lin CW, Shih JY, Yang PC, Hsiao CK, Lai LC and Chuang EY:
Identification of a novel biomarker, SEMA5A, for non-smallcell lung
carcinoma in nonsmoking women. Cancer Epidemiol Biomarkers Prev.
19:2590–2597. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Kuner R, Muley T, Meister M, Ruschhaupt M,
Buness A, Xu EC, Schnabel P, Warth A, Poustka A, Sültmann H and
Hoffmann H: Global gene expression analysis revealsspecific
patterns of cell junctions in non-small cell lung cancer subtypes.
Lung Cancer. 63:32–38. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhu CQ, Ding K, Strumpf D, Weir BA,
Meyerson M, Pennell N, Thomas RK, Naoki K, Ladd-Acosta C, Liu N, et
al: Prognostic and predictive gene signature for adjuvant
chemotherapy in resected non-small-cell lung cancer. J Clin Oncol.
10(28): 4417–4424. 2010. View Article : Google Scholar
|
|
60
|
Lo FY, Chang JW, Chang IS, Chen YJ, Hsu
HS, Huang SF, Tsai FY, Jiang SS, Kanteti R, Nandi S, et al: The
database of chromosome imbalance regions and genes resided in lung
cancer from Asian and Caucasian identified by array-comparative
genomic hybridization. BMC Cancer. 12:2352012. View Article : Google Scholar : PubMed/NCBI
|
